Related Experiment Video
Updated: Aug 14, 2026
05:46
Introduction of Intracapsular Rotary-cut Procedures (IRCP): A Modified Hysteromyomectomy Procedures Facilitating Fertility Preservation
Published on: January 17, 2019
Medical management of first trimester incomplete miscarriage using misoprostol
L B Coughlin1, D Roberts, N G Haddad
1Countess of Chester NHS Trust, Chester, UK. drlbc@aol.com
Summary
A single dose of oral misoprostol effectively managed incomplete miscarriage in women. This treatment resulted in a high success rate, avoiding the need for surgical intervention in most cases.
Area of Science:
- Obstetrics and Gynecology
- Reproductive Medicine
- Pharmacological Management of Miscarriage
Background:
- Incomplete miscarriage is a common obstetric complication.
- Retained products of conception require timely management to prevent complications.
- Medical management offers an alternative to surgical evacuation.
Purpose of the Study:
- To evaluate the efficacy of a single 400 microgram oral dose of misoprostol.
- To assess misoprostol's effectiveness in managing first-trimester incomplete miscarriage with retained products.
- To determine the rate of successful uterine evacuation and need for surgery.
Main Methods:
- Prospective study involving 131 women with first-trimester incomplete miscarriage.
- Transvaginal ultrasound used to measure retained products (15-50 mm).
- Treatment involved a single 400 microgram oral dose of misoprostol.
Main Results:
- Successful treatment (empty uterus post-misoprostol) achieved in 77.7% of women.
- Overall, 92.4% of women completed miscarriage management without surgery.
- Bleeding was mostly mild to moderate, lasting an average of 6.4 days.
- Adverse effects were generally mild, with no reported infections.
Conclusions:
- A single 400 microgram oral dose of misoprostol is an effective first-line treatment for incomplete miscarriage.
- Medical management with misoprostol can significantly reduce the need for surgical evacuation.
- Misoprostol offers a safe and effective option for managing retained products of conception.
Related Concept Videos
01:20Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
01:26Peptic Ulcer Disease IV: Management
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
01:19Mitral Valve Prolapse III: Nursing Management
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...